Validation of Nanosensor Oxygen Measurement

PHASE1RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
MItochondrial MyopathiesMitochondrial Disease
Interventions
DEVICE

Nanosensor

"The purpose of the study is to test a device called a nanosensor, which measures oxygen levels (a proxy of mitochondrial function) in muscle. The nanosensor has not been tested in humans nor has it been approved by the FDA. The study nanosensor measures 1.8 mm width x 6 mm length x 0.3 mm depth. Placement of the sterilized nanosensor involves a small incision for manual placement of the nanosensor in muscle forearm tissue."

Trial Locations (1)

19104

RECRUITING

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Children's Hospital of Philadelphia

OTHER